Immunohistochemistry Market Size, Share, Growth Analysis, By Product(Antibodies, Reagents, Kits), By Application(Diagnostics, Research), By End-user(Hospitals & diagnostic laboratories, research institutes, and others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2224 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 89 |Figures: 76

Immunohistochemistry Market Insights

Immunohistochemistry Market size was valued at USD 2.98 billion in 2022 and is poised to grow from USD 3.2 billion in 2023 to USD 5.28 billion by 2030, at a CAGR of 7.4% during the forecast period (2023-2030).

The implementation of automation and machine learning in immunohistochemistry (IHC) is revolutionizing the field and driving the market forward.

These technological advancements are streamlining and improving the efficiency of IHC processes, leading to more accurate and timely disease diagnosis. The automation of tasks such as staining, image analysis, and data interpretation reduces human error and increases productivity. Machine learning algorithms enable the identification and classification of tissue markers, enhancing the diagnostic capabilities of IHC.

Furthermore, the introduction of technologically advanced immunohistochemistry solutions is fueling market growth. These solutions offer improved sensitivity, specificity, and multiplexing capabilities, enabling researchers and pathologists to obtain more detailed and precise information from tissue samples.

The development of novel antibodies and reagents tailored for specific biomarkers expands the range of applications and enhances the diagnostic potential of IHC. The market is also benefiting from the increasing number of product approvals and launches of advanced immunohistochemistry systems.

Regulatory approvals validate the safety and efficacy of these systems, instilling confidence among healthcare professionals. The availability of cutting-edge advanced imaging, automation, and data analysis capabilities empowers researchers and clinicians to make more informed and accurate diagnoses, driving market growth.

US Immunohistochemistry Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 2.98 billion

Largest Segment

hospitals and diagnostic laboratories

Fastest Growth

hospitals and diagnostic laboratories

Growth Rate

7.4% CAGR

Global Immunohistochemistry Market by region
Country Share for North America (%)

To get more reports on the above market click here to Buy The Report

Immunohistochemistry Market Segmental Analysis

The market for occlusion devices is categorized by product, application, end-use, and region. Based on product, the market is segmented into antibodies, reagents, and kits. By application the market is segmented into diagnostics and research. By end-use, the market is segmented into hospitals & diagnostic laboratories, research institutes, and others. By region, the market is divided into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

Immunohistochemistry Market Analysis By Product

In 2022, the antibodies segment held the largest market share, accounting for 40.96% of the immunohistochemistry (IHC) market. Among antibodies, monoclonal antibodies and related products such as Fc-fusion, antibody fragments, and antibody-drug conjugates are widely used, leading to their dominance in terms of usage rate. Antibodies find applications across various fields such as pathology, neuropathology, and hematopathology.

The kits segment is expected to exhibit the fastest growth rate during the forecast period. These kits are compact and easy to use, driving their demand. Research laboratories and academic institutions often utilize IHC kits in small quantities for their research programs. The increasing number of research programs involving IHC assays is contributing to the growth of the kits segment. The convenience and ease of use provided by IHC kits are driving their adoption and fueling segment growth.

Immunohistochemistry Market Analysis By Application

In 2022, the diagnostics application segment held the largest revenue share, accounting for more than 69.16% of the market, and is expected to maintain its dominance throughout the forecast period. With the increasing prevalence of chronic diseases, the demand for IHC in the diagnostics field is projected to grow. The ability of IHC to provide valuable insights into disease pathology and aid in accurate diagnoses contributes to its widespread adoption in clinical settings. The diagnostics segment is expected to drive the growth of the immunohistochemistry market due to the rising need for effective disease diagnosis and management.

Global Immunohistochemistry Market by End-user, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Immunohistochemistry Market Regional Insights

In 2022, North America emerged as the dominant region, capturing the largest market share of over 38.39% in terms of revenue. Several factors contribute to the growth of the IHC market in North America. Firstly, the region is home to major market players and renowned research institutes, fostering innovation and advancements in IHC technology. Secondly, there is easy availability of IHC solutions, including antibodies, reagents, and instruments, facilitating the widespread adoption of IHC techniques.

Additionally, the region exhibits a higher uptake of technologically advanced IHC instruments, enabling efficient and accurate analysis of tissue samples. Lastly, the entry of newer IHC solutions and product launches further drives the growth of the market in North America. The region's well-established healthcare infrastructure and the presence of skilled professionals also contribute to its market dominance.

Global Immunohistochemistry Market by region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Immunohistochemistry Market Dynamics

Immunohistochemistry Market Drivers

Increasing Prevalence Of Chronic Diseases

  • The growing burden of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has led to a rise in the demand for accurate and reliable diagnostic techniques like IHC. IHC plays a crucial role in the detection, characterization, and classification of various diseases, enabling effective treatment planning and patient management. The rising prevalence of chronic diseases globally is driving the adoption of IHC, leading to market growth.
  • Continuous advancements in IHC technology, including the development of new antibodies, reagents, and automated staining systems, have significantly improved the efficiency and accuracy of IHC assays. These technological advancements have streamlined the workflow, reduced turnaround time, and enhanced the sensitivity and specificity of IHC results. The introduction of multiplex IHC, digital pathology, and image analysis software has further expanded the applications of IHC, enabling researchers and pathologists to obtain more comprehensive and detailed information from tissue samples.

Immunohistochemistry Market Restraints

High Cost Of IHC Procedures

  • The cost associated with IHC procedures, including the purchase of antibodies, reagents, and instruments, as well as the need for skilled personnel, can be a significant barrier to market growth. The high cost of IHC testing and limited reimbursement coverage in certain regions may hinder the widespread adoption of IHC techniques, especially in resource-constrained settings. Affordability and cost-effectiveness remain key challenges for the broader utilization of IHC.
  • The interpretation of IHC results can be subjective and challenging, requiring expertise and experience in pathological analysis. Variability in staining protocols, antibody specificity, and scoring systems can lead to inconsistent results and inter-laboratory variability. Standardization of IHC procedures and interpretation criteria across different laboratories and pathologists remains a challenge.

Request Free Customization of this report to help us to meet your business objectives.

Immunohistochemistry Market Competitive Landscape

The competitive landscape of the immunohistochemistry (IHC) market is characterized by the presence of several key players, including established multinational companies as well as smaller regional and local players. These companies compete based on factors such as product portfolio, technological advancements, pricing, and distribution networks. Major players in the market invest heavily in research and development activities to launch innovative IHC solutions, expand their product offerings, and enhance their market presence. They also focus on strategic collaborations, partnerships, and acquisitions to strengthen their market position and gain a competitive edge. Additionally, players in the market actively engage in marketing and promotional activities to increase awareness about their IHC products and capture a larger customer base. Overall, the market is highly competitive, with companies vying to cater to the growing demand for accurate and reliable diagnostic solutions in the field of pathology and research.

Immunohistochemistry Market Top Player’s Company Profiles

  • Agilent Technologies Inc. (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Thermo Fisher Scientific Inc. (United States)
  • Danaher Corporation (United States)
  • Merck KGaA (Germany)
  • Abcam plc (United Kingdom)
  • Bio-Rad Laboratories, Inc. (United States)
  • Cell Signaling Technology, Inc. (United States)
  • PerkinElmer, Inc. (United States)
  • Abnova Corporation (Taiwan)
  • Biocare Medical, LLC (United States)
  • Leica Biosystems Nussloch GmbH (Germany)
  • Sakura Finetek Japan Co., Ltd. (Japan)
  • Agendia NV (Netherlands)
  • Biogenex Laboratories (United States)
  • BioGenex (United States)
  • Bethyl Laboratories, Inc. (United States)
  • Diagenode Diagnostics (Belgium)
  • R&D Systems, Inc. (United States)
  • Santa Cruz Biotechnology, Inc. (United States)

Immunohistochemistry Market Recent Developments

  • In March 2023, Aptamer Group announced the launch of Optimer-Fc, a new reagent solution specifically designed for use in automated immunohistochemistry (IHC) workflows. This innovative product is expected to provide researchers and diagnosticians with enhanced capabilities for exploring emerging biomarkers in the field of diagnostics and research. By offering improved sensitivity and specificity, Optimer-Fc has the potential to advance the accuracy and reliability of IHC-based analyses, contributing to better disease detection and characterization.

Immunohistochemistry Key Market Trends

  • Automation technologies, including robotic systems and advanced image analysis software, are being integrated into IHC platforms to improve efficiency, accuracy, and reproducibility. This trend enables faster and standardized analysis of tissue samples, reducing human error and enhancing diagnostic outcomes. Additionally, the integration of artificial intelligence and machine learning algorithms in IHC data analysis is gaining momentum, allowing for more precise quantification and interpretation of staining patterns. The shift towards automation and digitalization is expected to revolutionize the field of IHC and streamline laboratory workflows in pathology and research settings.

Immunohistochemistry Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, the future prospects of the immunohistochemistry (IHC) market are promising. Factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, and advancements in diagnostic techniques are expected to drive market growth. Additionally, the growing focus on precision medicine and targeted therapies is fueling the demand for IHC assays in drug development and patient stratification. Technological advancements, such as multiplex IHC and digital pathology, are further enhancing the capabilities of IHC, allowing for more comprehensive analysis and interpretation of tissue samples. Moreover, the expanding applications of IHC in research and clinical settings, along with the emergence of novel biomarkers, present significant opportunities for market expansion. With ongoing advancements and innovations, the IHC market is poised for continued growth in the coming years.

Report Metric Details
Market size value in 2023 USD 2.98 billion
Market size value in 2031 USD 5.28 billion
Growth Rate 7.4%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Antibodies, Reagents, Kits
  • Application
    • Diagnostics, Research
  • End-user
    • Hospitals & diagnostic laboratories, research institutes, and others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Agilent Technologies Inc. (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Thermo Fisher Scientific Inc. (United States)
  • Danaher Corporation (United States)
  • Merck KGaA (Germany)
  • Abcam plc (United Kingdom)
  • Bio-Rad Laboratories, Inc. (United States)
  • Cell Signaling Technology, Inc. (United States)
  • PerkinElmer, Inc. (United States)
  • Abnova Corporation (Taiwan)
  • Biocare Medical, LLC (United States)
  • Leica Biosystems Nussloch GmbH (Germany)
  • Sakura Finetek Japan Co., Ltd. (Japan)
  • Agendia NV (Netherlands)
  • Biogenex Laboratories (United States)
  • BioGenex (United States)
  • Bethyl Laboratories, Inc. (United States)
  • Diagenode Diagnostics (Belgium)
  • R&D Systems, Inc. (United States)
  • Santa Cruz Biotechnology, Inc. (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Immunohistochemistry Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Immunohistochemistry Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Immunohistochemistry Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunohistochemistry Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunohistochemistry Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Immunohistochemistry Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Immunohistochemistry Market size was valued at USD 2.98 billion in 2022 and is poised to grow from USD 3.2 billion in 2023 to USD 5.28 billion by 2030, at a CAGR of 7.4% during the forecast period (2023-2030).

The competitive landscape of the immunohistochemistry (IHC) market is characterized by the presence of several key players, including established multinational companies as well as smaller regional and local players. These companies compete based on factors such as product portfolio, technological advancements, pricing, and distribution networks. Major players in the market invest heavily in research and development activities to launch innovative IHC solutions, expand their product offerings, and enhance their market presence. They also focus on strategic collaborations, partnerships, and acquisitions to strengthen their market position and gain a competitive edge. Additionally, players in the market actively engage in marketing and promotional activities to increase awareness about their IHC products and capture a larger customer base. Overall, the market is highly competitive, with companies vying to cater to the growing demand for accurate and reliable diagnostic solutions in the field of pathology and research. 'Agilent Technologies Inc. (United States)', 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Thermo Fisher Scientific Inc. (United States)', 'Danaher Corporation (United States)', 'Merck KGaA (Germany)', 'Abcam plc (United Kingdom)', 'Bio-Rad Laboratories, Inc. (United States)', 'Cell Signaling Technology, Inc. (United States)', 'PerkinElmer, Inc. (United States)', 'Abnova Corporation (Taiwan)', 'Biocare Medical, LLC (United States)', 'Leica Biosystems Nussloch GmbH (Germany)', 'Sakura Finetek Japan Co., Ltd. (Japan)', 'Agendia NV (Netherlands)', 'Biogenex Laboratories (United States)', 'BioGenex (United States)', 'Bethyl Laboratories, Inc. (United States)', 'Diagenode Diagnostics (Belgium)', 'R&D Systems, Inc. (United States)', 'Santa Cruz Biotechnology, Inc. (United States)'

The growing burden of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has led to a rise in the demand for accurate and reliable diagnostic techniques like IHC. IHC plays a crucial role in the detection, characterization, and classification of various diseases, enabling effective treatment planning and patient management. The rising prevalence of chronic diseases globally is driving the adoption of IHC, leading to market growth.

Automation technologies, including robotic systems and advanced image analysis software, are being integrated into IHC platforms to improve efficiency, accuracy, and reproducibility. This trend enables faster and standardized analysis of tissue samples, reducing human error and enhancing diagnostic outcomes. Additionally, the integration of artificial intelligence and machine learning algorithms in IHC data analysis is gaining momentum, allowing for more precise quantification and interpretation of staining patterns. The shift towards automation and digitalization is expected to revolutionize the field of IHC and streamline laboratory workflows in pathology and research settings.

In 2022, North America emerged as the dominant region, capturing the largest market share of over 38.39% in terms of revenue. Several factors contribute to the growth of the IHC market in North America. Firstly, the region is home to major market players and renowned research institutes, fostering innovation and advancements in IHC technology. Secondly, there is easy availability of IHC solutions, including antibodies, reagents, and instruments, facilitating the widespread adoption of IHC techniques.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Product ID: SQMIG35H2224

$5,300
BUY NOW GET FREE SAMPLE